FDA Guidance On Nocturnal Home Hemodialysis Outlines Clinical Trial Needs
This article was originally published in The Gray Sheet
Executive Summary
An April 15 FDA guidance tells makers of nocturnal home hemodialysis systems what sorts of clinical trials they should perform to smooth the FDA pre-market clearance process
You may also be interested in...
Nightly Home Hemodialysis Gains First FDA Clearance
NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.
Fresenius Acquires Renal Solutions, Next-Gen Home Dialysis Technology
The Nov. 29 acquisition of Renal Solutions Inc. (RSI) by Fresenius Medical Care is expected to give Fresenius a better hold on the home therapy market for kidney dialysis
FDA Panel Explores Nocturnal Hemodialysis Device, Trial Design
FDA's Gastroenterology & Urology Devices Panel emphasized the importance of human factors considerations for nocturnal hemodialysis devices during a June 8 meeting in Gaithersburg, Md